의료진

학력
- 인하대학교 의과대학 의학 학사
- 서울대학교 의과대학 의학 석사
- 서울대학교 의과대학 의학 박사
경력
- 예방의학전문의 / 정보의학인증의 / 노인의학세부전문의
- 인하대병원 인턴
- 서울대학교 의과대학 예방의학교실 전공의
- 제1야전군 사령부 예방의학장교
- 국방부 보건정책과 예방의무담당관
- 필리핀 합동지원단 방역반장
- 특수전사령부 국제평화지원단 의무반장
- 서울대학교병원 약물안전센터 진료교수
- 서울대학교병원 정보화실 겸직교수
- 서울대학교 의과대학 예방의학교실 겸임교수
직책
- 울산대학교 의과대학 예방의학교실 부교수
- 울산광역시 심뇌혈관질환 예방관리사업 지원단장
- 울산광역시 감염병관리지원단장
- 울산대학교병원 지역의약품안전센터장
- 울산대학교병원 지역암센터 사업부장
- 대한예방의학회 총무이사
- 한국보건정보통계학회 총무이사
- 대한약물역학위해관리학회 국제협력위원장
- 한국원격의료학회 이사
- 대한근거기반의학회 학술위원
- 대한암예방학회 홍보위원
- 식품의약품안전처 중앙약사심의위원회 위원장
- 건강보험심사평가원 약제급여평가위원
- 한국보건의료정보원 표준전자의무기록 인증기준 개발 자문위원
- 의료기관평가인증원 중앙환자안전센터 정보통계 자문위원
- 질병관리청 건강위해전문가 자문위원
- 질병관리청 예방접종피해보상 전문위원회 위원
- 보건복지부 첨단재생바이오 전문위원
연구과제
- [한국의약품안전관리원] 공통데이터모델을 이용한 양성자펌프억제제 부작용 조사. 2019
- [식품의약품안전처] 중증 약물알레르기 생체지표 발굴등 부작용 저감화를 위한 연구. 2020.
- [한국의약품안전관리원] 공통데이터모델을 이용한 급성 췌장염 부작용 조사. 2020.
- [식품의약품안전처] 의약품 부작용 피해구제 차등 지급 관리 방안 조사·연구. 2020.
- [한국의약품안전관리원] 졸피뎀 부작용 실태조사 및 관리방안. 2020.
- [식품의약품안전처] 약물부작용 예측을 위한 생체지표 검증 연구. 2021.
- [한국의약품안전관리원] 서울대학교병원 EHR 기반 공통데이터모델 확대 구축. 2021.
- [한국의약품안전관리원] 코로나19 치료제 이상사례 현황 파악 및 위험 분석. 2021.
- [한국보건의료정보원] EMR 시스템 인증기준 표준개발 및 확산지원. 2021.
- [한국의약품안전관리원] 울산대학교병원 EHR 기반 공통데이터모델 확대 구축. 2023.
- [한국의약품안전관리원] 울산대학교병원 EHR 기반 공통데이터모델 운영. 2024.
- [국가통합바이오빅데이터구축사업단] 제2차 국가 통합 바이오 빅데이터 구축 사업. 2024.
- [질병관리청] 건강위해 예방 및 관리를 위한 로드맵 구축 연구. 2025.
- [질병관리청] 군(軍) 감염병 대응 및 관리역량 강화 방안 연구. 2025.

Lee DY, Lee SB, Lim KM, Choi YJ, Kang DY. Survey on caregiver competency and retraining needs. Public Health Nurs. 2024 Nov-Dec;41(6):1265-1270. doi: 10.1111/phn.13376. Epub 2024 Aug 2. PMID: 39092978.
Sin C, Lee DY, Kim H, Im HS, Koh SJ, Kang DY. Effectiveness of self-reported management program of cancer patients. Digit Health. 2024 Jul 23;10:20552076241253090. doi: 10.1177/20552076241253090. PMID: 39055783; PMCID: PMC11271138.
Lee D, Choi B, Moon SH, Choi EY, Kang DY. Awareness of Drug Safety System in Local Clinics in Korea. Pharmacoepidemiology and Risk Management 2024;16:57-64.https://doi.org/10.56142/perm.24.0008
Kang H, Kang CK, Im JH, Cho Y, Lee JY, Kang DY. Adverse Drug Events Associated With Remdesivir in Real-World Hospitalized Patients With COVID-19, Including Vulnerable Populations: A Retrospective Multicenter Study. J Korean Med Sci. 2023 Nov 13;38(44):e346. doi: 10.3346/jkms.2023.38.e346. PMID: 37967875; PMCID: PMC10643246.
Lee S, Lee D, Kim J, Moon SH, Lee G, Choi B, Kim YS, Im JH, Kang DY. Analysis of Treatment-Related Adverse Events in Hospitalized Patients with Coronavirus Disease 2019. Pharmacoepidemiology and Risk Management 2023;15:128-136. https://doi.org/10.56142/perm.23.0010
Im JH, Lee DY, Baek JH, Lee SJ, Jung S, Kim E, Lee JS, Kang DY. Comparison of Cefazolin/Metronidazole to Ampicillin/Sulbactam as Preoperative Antibiotics in Colorectal Surgery: A Retrospective, Single-Center Cohort Study. Antibiotics. 2023; 12(9):1381. https://doi.org/10.3390/antibiotics12091381
Lee DY, Lee SB, Park YI, Lee JG, Park YH, Lee SY, Kang DY. Competency Survey of Caregivers in Medical Tourism Special Zone and Other Regions. J Health Info Stat. 2023;48(2):140-147. doi : https://doi.org/10.21032/jhis.2023.48.2.140
Choe S, Lee S, Park CH, Lee JH, Kim HJ, Byeon SJ, Choi JH, Yang HJ, Sim DW, Cho BJ, Koo H, Kang MG, Jeong JB, Choi IY, Kim SH, Kim WJ, Jung JW, Lhee SH, Ko YJ, Park HK, Kim JH, Kang DY. Development and Application of an Active Pharmacovigilance Framework Based on Electronic Healthcare Records from Multiple Centers in Korea. Drug Saf. 2023 May 27. doi: 10.1007/s40264-023-01296-2. Epub ahead of print. PMID: 37243963.
Kang DY, Lee DY, Kim E, Lee SJ, Baek JH, Lee JS, Park MY, Im JH. Adverse events of a third dose of BNT162b2 mRNA COVID-19 vaccine among Korean healthcare workers. Medicine (Baltimore). 2023 Mar 17;102(11):e33236. doi: 10.1097/MD.0000000000033236. PMID: 36930126; PMCID: PMC10018524.
Kang DY, Park S, Ahn H, Kim N, Yoon JH, Yang BR. Effect of weekend catch-up sleep on high-sensitivity C-reactive protein levels according to bedtime inconsistency: a populationbased cross-sectional study. Sci Rep. 2022 Dec 14;12(1):21619. doi: 10.1038/s41598-022-25787-x. PMID: 36517526; PMCID: PMC9751111.
Moon SH, Kim HH, Nam D, Moon Y, Kang M, Choi IY, Byeon S, Yang H, Kim S, Kim K, Kang DY. Risk Factors for Clostridium difficile Infection in Antibiotic Use Inpatients Based on Common Data Model. Pharmacoepidemiology and Risk Management 2022;14:86-92. https://doi.org/10.56142/2022.14.1.86.
Kang DY, Ahn YH, Park SB, Kim HH, Kim HJ, Park GY, Yoon SH, Choi YH, Lee SY, Kang HR. Allergic-like Hypersensitivity Reactions to Gadolinium-based Contrast Agents: An 8-year Cohort Study of 154 539 Patients. Radiology. 2022 Feb 22:210545. doi: 10.1148/radiol.210545. Epub ahead of print. PMID: 35191737.
Kang DY, Kim H, Ko S, Kim H, Shinn J, Kang MG, Byeon SJ, Choi JH, Shin SY, Kim HS. Sodium-Glucose Cotransporter-2 Inhibitor-Related Diabetic Ketoacidosis: Accuracy Verification of Operational Definition. J Korean Med Sci. 2022 Feb 21;37(7):e53. doi: 10.3346/jkms.2022.37.e53. PMID: 35191230; PMCID: PMC8860766.
Kang DY, Lee SY, Ahn YH, Yoon SH, Choi YH, Lee W, Kang HR. Incidence and risk factors of late adverse reactions to low-osmolar contrast media: A prospective observational study of 10,540 exposures. Eur J Radiol. 2022 Jan;146:110101. doi: 10.1016/j.ejrad.2021.110101. Epub 2021 Dec 10. PMID: 34952368.
Kim HJ, Kim HH, Park S, Yeom HJ, Jang JY, Park G, Kang H, Kang DY. Adverse Reactions after the Second Dose of ChAdOx1 COVID-19 Vaccine in Healthcare Workers. Pharmacoepidemiology and Risk Management 2021;13:62-69. https://doi.org/10.56142/2021.13.2.62.
Kim HJ, Kim HH, Park G, Kang DY. Precautions for COVID-19 Vaccination. Pharmacoepidemiology and Risk Management 2021;13:38-44. https://doi.org/10.56142/2021.13.1.38.
Kim HJ, Moon M, Kim HH, Park S, Kang R, Park G, Kang H, Kang DY. Improving the Prescription System to Prevent Adverse Drug Reactions. Pharmacoepidemiology and Risk Management 2021;13:24-29. https://doi.org/10.56142/2021.13.1.24.
Kang DY, Yun J, Lee SY, Koh YI, Sim DW, Kim S, Nam YH, Park JW, Kim SH, Ye YM, Park HK, Kim MH, Jee YK, Jung JW, Yang MS, Kim SH, Lee JK, Kim CW, Hur GY, Kim MY, Park SJ, Kwon YE, Choi JH, Kim JH, Kim SH, La HO, Kang MG, Park CS, Lee SM, Jeong YY, Kim HK, Jin HJ, Jeong JW, Lee J, Lee YW, Lee SE, Kim MS, Kang HR; Korean Severe Cutaneous Adverse Reactions Consortium. A Nationwide Study of Severe Cutaneous Adverse Reactions Based on the Multicenter Registry in Korea. J Allergy Clin Immunol Pract. 2021 Feb;9(2):929-936.e7. doi: 10.1016/j.jaip.2020.09.011. Epub 2020 Sep 19. PMID: 32961314.
Park G, Sohn JE, Moon M, Lee JY, Kang HR, Kang DY. Characteristics of Adverse Drug Reactions of Central Muscle Relaxants Including Eperisone: Analysis of KAERS Data. Pharmacoepidemiology and Risk Management 2020;12:79-84.
Kang DY, Chung SJ, Lee W, Lee SB, Kim S, Lee SE, Sim DW, Kang MG, Park KH, Jung JW, Yun J, Kang HR. HLA-DRB1*15: 02 Is Associated With Iodinated Contrast Media-Related Anaphylaxis. Invest Radiol. 2020 May;55(5):304-309. doi: 10.1097/RLI.0000000000000644. PMID: 31985601.
Kang DY, Cha MJ, Lee W, Yoon SH, Choi YH, Byun JS, Lee J, Kim YH, Choo KS, Cho BS, Jeon KN, Jung JW, Kang HR. Hypersensitivity Reactions to Iodinated Contrast Media: A Multicenter Study of 196 081 Patients. Radiology. 2019 Oct;293(1):117-124. doi: 10.1148/radiol.2019190485. Epub 2019 Sep 3. PMID: 31478801.
Kang DY, Moon M, Lee SY, Yang MS, Lee JY, Kang HR. Cephalosporin Skin Test Positivity before Administration and Associated Factors. Pharmacoepidemiology and Risk Management 2019;11:37-43.
Kang DY, Jang DY, Sohn KH, Kang SY, Kim JY, Cho SH, Kang HR. Optimal methods to detect DRESS (drug reaction with eosinophilia and systemic symptoms) syndrome by electronic medical records. Allergy Asthma Respir Dis. 2018;6(3):149-154.
Choi KR, Yun JY, Kim NH, Kang HR, Kang DY. A Case of Teicoplanin-Induced Neutropenia in Patients with Vancomycin Hypersensitivity. Pharmacoepidemiology and Risk Management 2018;10:36-39.
Yun JY, Choi KR, Kim NH, Kang HR, Kang DY. A Case of Anaphylaxis by Dextromethorphan. Pharmacoepidemiology and Risk Management 2018;10:40-42.
Kang DY. The Active Pharmacovigilance System: A Postscript of Visiting the Harvard Pilgrim Health Care Institute. Pharmacoepidemiology and Risk Management 2017;9:45-47.
Kang DY, Lee J, Sohn KH, Kang SY, Cho YS, Kang HR. A case series of eperisone-induced immediate hypersensitivity. Allergy Asthma Respir Dis. 2017;5(4):228-231.
Kang DY, Ahn KM, Kang HR, Cho SH. Past, present, and future of pharmacovigilance in Korea. Asia Pac Allergy. 2017 Jul;7(3):173-178. doi: 10.5415/apallergy.2017.7.3.173. Epub 2017 Jul 19. PMID: 28765823; PMCID: PMC5537083.
Kang DY, Sohn KH, Kang SY, Yoon SH, Choi YH, Kang HR. Understanding and Management of Hypersensitivity Reactions to Iodinated Contrast Media. Pharmacoepidemiology and Risk Management 2016;8:19-23.
Kang DY, Park S, Rhee CW, Kim YJ, Choi NK, Lee J, Park BJ. Zolpidem use and risk of fracture in elderly insomnia patients. J Prev Med Public Health. 2012 Jul;45(4):219-26. doi: 10.3961/jpmph.2012.45.4.219. Epub 2012 Jul 31. PMID: 22880153; PMCID: PMC3412984.

날짜	1 수	2 목	3 금	4 토	5 일	6 월	7 화	8 수	9 목	10 금	11 토	12 일	13 월	14 화	15 수	16 목	17 금	18 토	19 일	20 월	21 화	22 수	23 목	24 금	25 토	26 일	27 월	28 화	29 수	30 목
오전
오후

울산대학교병원

울산대학교병원 주메뉴

With 울산대학교병원

예방의학과강동윤

상세정보

학력

경력

직책

연구과제

논문

언론

영상